BIS icon

ProShares UltraShort NASDAQ Biotechnology
BIS

Overview Fund Activity

19 hedge funds and large institutions have $46.6M invested in ProShares UltraShort NASDAQ Biotechnology in 2015 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 7 closing their positions.

Holders
19
Holders Change
–
Holders Change %
0%
% of All Funds
0.53%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
7
Reduced
3
Closed
7
Calls
$24M
Puts
$4.05M
Net Calls
+$19.9M
Net Calls Change
+$18.8M

Top Buyers

1
AAP
1
Ardsley Advisory Partners
Connecticut
$12.5M
2
VF
2
Virtu Financial
New York
$5.61M
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$3.63M
4
Citadel Advisors
4
Citadel Advisors
Florida
$3.03M
5
TRCT
5
Tower Research Capital (TRC)
New York
$2.9M

Top Sellers

1
HVC
1
Healthcare Value Capital
New Jersey
$0
2
HCMT
2
Highland Capital Management (Texas)
Texas
$14.7M
3
BHA
3
Beech Hill Advisors
New York
$0
4
Morgan Stanley
4
Morgan Stanley
New York
$686K
5
ID
5
Integral Derivatives
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
TCM
26
Tradewinds Capital Management
Washington
– – -75 Closed
ST
27
Spot Trading
Illinois
– – – –
1
2